Provost Jean-Claude
Known title: Chief Medical OfficerCIK: 0001960060
Associated companies
Transaction History
| LNTH | ▼ Sell | Tax Withholding | 546 | $36K | 3/5/2024 | View on chart |
| LNTH | ▲ Buy | Grant | 18,564 | $0 | 3/1/2024 | View on chart |
| LNTH | ▲ Buy | Grant | 16,359 | $0 | 3/2/2023 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 16, 2026
Lantheus Holdings receives Mizuho downgrade to neutral
Lantheus Holdings was downgraded to neutral by Mizuho, which also cut its price target to $109. The downgrade appeared alongside other recent analyst cuts highlighted in a Benzinga roundup of top downgrades. The new target sits near the current analyst consensus of $107.22 and close to the stock’s 52‑week high, while the RSI is around the midpoint.
Lantheus Holdings receives Mizuho downgrade to neutral. Lantheus Holdings was downgraded to neutral by Mizuho, which also cut its price target to $109. The downgrade appeared alongside other recent analyst cuts highlighted in a Benzinga roundup of top downgrades. The new target sits near the current analyst consensus of $107.22 and close to the stock’s 52‑week high, while the RSI is around the midpoint.